Kieger Impact Healthcare Fund Class A CHF (H) Accumulating

Reference Data

ISIN LU2207278404
Valor Number 120730677
Bloomberg Global ID
Fund Name Kieger Impact Healthcare Fund Class A CHF (H) Accumulating
Fund Provider Kieger AG Kieger AG
Limmatstrasse 264, CH-8005 Zürich
Phone: +41 44 444 18 44
Web: https://kieger.com/
E-Mail: info@kieger.com
Fund Provider Kieger AG
Representative in Switzerland ACOLIN Fund Services AG
Zürich
Phone: +41 44 396 96 96
Distributor(s)
Asset Class Equities
EFC Category
Distribution Policy Accumulation
Home Country Luxembourg
Issuing Condition The fund does not charge any issuing commission and/or fees (units are issued at the NAV)
Redemption Condition The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV)
Investment Strategy *** The investment objective of the Sub-Fund is to achieve long term capital growth by principally investing in equities of healthcare and healthcare related companies or issuers worldwide (including Emerging Markets) with a focus on issuers that contribute to the realisation of the healthcare related United Nations Sustainable Development Goals ("SDGs"). No guarantee can be given that the investment objective will be achieved.
Peculiarities

Fund Prices

Current Price * 83.55 CHF 30.10.2024
Previous Price * 83.36 CHF 29.10.2024
52 Week High * 93.94 CHF 28.12.2023
52 Week Low * 76.63 CHF 10.11.2023
NAV * 83.55 CHF 30.10.2024
Issue Price *
Redemption Price *
Closing Price *
Indicative Minimum Price
Fund Assets *** 72,261,320
Unit/Share Assets *** 3,587,280
Trading Information SIX

Performance

YTD Performance -10.33% 29.12.2023
30.10.2024
1 month -4.41% 30.09.2024
30.10.2024
3 months -4.81% 30.07.2024
30.10.2024
6 months -3.11% 30.04.2024
30.10.2024
1 year +8.34% 30.10.2023
30.10.2024
2 years -16.05% 31.10.2022
30.10.2024
3 years -16.45% 31.08.2022
30.10.2024
5 years - -

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI
ADDI Date

Top 10 Holdings ***

ResMed Inc 4.00%
Tandem Diabetes Care Inc 3.74%
Hikma Pharmaceuticals PLC 3.63%
Ambu AS Class B 3.43%
Sandoz Group AG Registered Shares 3.39%
Guardant Health Inc 3.37%
Ionis Pharmaceuticals Inc 3.34%
GSK PLC 3.34%
Natera Inc 3.32%
BioNTech SE ADR 3.31%
Last data update 30.04.2024

Cost / Risk

TER *** 1.27%
TER date *** 30.09.2023
Performance Fee ***
PTR
Max. Management Fee *** 1.00%
Ongoing Charges *** 1.22%
SRRI ***
SRRI date *** 30.09.2022

ESG Fund Ratings

Low Carbon Designation ***
ESG Rating Overall ***
ESG Rating Corporate ***
ESG Rating Sovereign ***
% AuM H&S Controversies ***

Breakdowns

Countries ***

Stock Sectors ***

Bond Sectors ***

ESG Carbon Metrics

Avg Carbon Risk Score ***
Avg Carbon Risk Cat Avg ***
% AuM Covered Carbon ***
Avg Fossil Fuel Exposure ***
Fossil Fuel Cat Avg ***

ESG Strategy

Strategy Level 1 ***
Strategy Level 2 ***
Strategy Level 3 ***
Exclusions Level 1 ***
Exclusions Level 2 ***

* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)